RAS Pathway Mutations Are Associated with Progression after Hypomethylating Agent Therapy in Chronic Myelomonocytic Leukemia
Guillermo Montalban-Bravo,Faezeh Darbaniyan,Kelly S. Chien,Danielle Hammond,Rashmi Kanagal-Shamanna,Tapan M. Kadia,Courtney D. DiNardo,Naval Daver,Farhad Ravandi,Elias Jabbour,Naveen Pemmaraju,Nicholas Short,Koichi Takahashi,Zeev E. Estrov,Sherry A. Pierce,Hagop Kantarjian, Guillermo Garcia-Manero Blood（2022）
AI 理解论文
溯源树
样例
